UBS Upgrades Cognizant Tech. (CTSH) to Buy; Cites Strong Positioning, Discretionary Project Spending
Get Alerts CTSH Hot Sheet
Price: $67.52 -0.37%
Rating Summary:
12 Buy, 25 Hold, 6 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
12 Buy, 25 Hold, 6 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
UBS upgrades Cognizant Technology Solutions (Nasdaq: CTSH) from Neutral to Buy and raises its price target from $50 up to $58.
Analyst Steven Milunovich highlights the following key positives:
For FY14, UBS raises its revenue growth estimate by 1 point to 18.5 percent and EPS by 2 cents to $2.57.
Analyst Steven Milunovich highlights the following key positives:
- it is well positioned for the current demand environment;
- we expect discretionary project spending to be solid this year; and
- a more formal capital return policy could be announced later this year; and (4) the stock could see further multiple expansion.
Cognizant is well positioned for the current IT environment in that IT budgets are under pressure with a focus on cost optimization (Cognizant's "run better"), and savings are being spent on new technologies (its "run different"). Cognizant is one of the few vendors equally credible in both, which it calls dual mandates. Our UBS CIO Survey published today suggests this tepid spending could continue for some time.
For FY14, UBS raises its revenue growth estimate by 1 point to 18.5 percent and EPS by 2 cents to $2.57.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cognizant (CTSH) and Microsoft (MSFT) announce global partnership to expand adoption of generative AI
- Smurfit Kappa Group PLC (SKG:ID) PT Raised to EUR48 at JPMorgan
- Skandinaviska Enskilda Banken AB (SEBA:SS) (SKVKY) PT Raised to SEK126 at Barclays
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst PT Change, UpgradesRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!